Outcome and adverse events in patients with chronic hepatitis C treated with direct-acting antivirals: a clinical randomized study
European journal of gastroenterology & hepatology, 2018.
We found no difference in AEs possibly related to the DAA regimen in patients with CHC, but surprisingly, AEs possibly related to the DAA regimen persisted in a significant number of patients after treatment. This finding can be of importance for clinicians in relation to patient information concerning AEs possibly related to DAA treatmen...More
Full Text (Upload PDF)